Satisfaction of allergic patients treated with house dust mite sublingual immunotherapy

Sublingual immunotherapy (SLIT) has been used for more than three decades as a therapeutic strategy for the treatment of allergic diseases. Studies have demonstrated its efficacy and safety and numerous clinical trials have evaluated these parameters. In the present study, through patient perception, patient satisfaction with the use of SLIT treatment against house dust mites was investigated and the results showed a high perception of satisfaction in allergic patients undergoing SLIT against house dust mites.

Click on the following link to see the full article:

Interview with Vanesa García, Quality Assurance Manager at Asac Pharmaceutical Immunology
Efficacy of House Dust Mite Sublingual Immunotherapy in Patients with Atopic Dermatitis: A Randomized, Double-Blind, Placebo-Controlled Trial.

Last News